Trial Profile
A prospective trial to evaluate the efficacy and safety of fingolimod in patients with relapsing–remitting multiple sclerosis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Apr 2016
Price :
$35
*
At a glance
- Drugs Fingolimod (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 29 Apr 2016 New trial record